Target or Decoy: Are Neuroscientists Pursuing the Right Target?

This blog is about the latest research in degenerative diseases. | Continue reading


@padiracinnovation.org | 2 years ago

Bosutinib may stop the disease progression for some ALS patients

Modeling neurodegenerative diseases is difficult because of poor access to human samples. Animal models fail to to model the disease due to critical | Continue reading


@padiracinnovation.org | 2 years ago

CuATSM is not tolerated at a high dose in a mice model of ALS

It has been known for several decades that Cu(II)ATSM belongs to a class of molecules with anti-inflammatory and antioxidant effects. By Jynto via | Continue reading


@padiracinnovation.org | 2 years ago

In Vitro Generation of Posterior Motor Neurons from Human Pluripotent Stem Cells

The ability to generate spinal cord motor neurons from human pluripotent stem cells (hPSCs) would be a major milestone in motor neuron-based diseases | Continue reading


@padiracinnovation.org | 2 years ago

Replacing defective neurons in a Parkinson's disease rat model

A major limiting factor for cell therapy in Parkinson's disease is the poor survival and reinnervation capacity of grafted dopaminergic neurons, | Continue reading


@padiracinnovation.org | 2 years ago

Two years later: A report on an implantable Brain-Computer Interface

The goal of CLINATEC® Brain Computer Interface Project is to improve tetraplegic subjects’ quality of life by allowing them to interact with their | Continue reading


@padiracinnovation.org | 2 years ago

Sustained astrocyte reactivity could worsen Alzheimer's disease

While astrocytes normally help fight β-amyloid plaque deposition, sustained astrocyte reactivity could lead to astrocyte dystrophy, gray matter | Continue reading


@padiracinnovation.org | 2 years ago

Using nanoparticles and peripheral clearance in Alzheimer's disease mice model

This is another paper using light for targeting β-amyloid in Alzheimer disease with light in a very interesting strategy. It's known that | Continue reading


@padiracinnovation.org | 2 years ago

Paradoxical Lucidity in Alzheimer

This post during the summer break will deal with something different from the usual content on this web site. Paradoxical lucidity refers to an | Continue reading


@padiracinnovation.org | 2 years ago

Ell's sense of starvation triggers TDP-43 misfolding

It’s unknown why misfolded aggregates appear in cells cytosol during neurodegenerative diseases. If the forming mechanism was elucidated it would | Continue reading


@padiracinnovation.org | 2 years ago

The Risk of Alzheimer's Disease After Acute Appendicitis

It is well known that approximately 10% cognitively well patients undergoing surgery will develop symptoms of cognitive dysfunction after their | Continue reading


@padiracinnovation.org | 2 years ago

Neurotoxic fungus and amyotrophic lateral sclerosis

ALS does not have a single cause, on the contrary every case of ALS is probably induced by a combination of factors that will lead to cellular | Continue reading


@padiracinnovation.org | 2 years ago

Beta-glucan food improves behavior and alpha-synuclein levels in autism disorder

This blog mainly deals with the three main neurodegenerative diseases, Alzheimer's, Parkinson's and ALS. Unfortunately, in real life, | Continue reading


@padiracinnovation.org | 2 years ago

Does ALS have anything in common with diabetes?

Metabolic disorders are associated with the progression of amyotrophic lateral sclerosis. This new study by Tanya S McDonald and colleagues from the | Continue reading


@padiracinnovation.org | 2 years ago

Direct involvement of the integrated stress response (ISR) in cognitive decline

Researchers of University of California at San Francisco, led by Karen Krukowski and Susanna Rosi have provided evidence for a direct involvement of | Continue reading


@padiracinnovation.org | 2 years ago

A possible link between childhood trauma and Alzheimer disease?

Two recent articles, one about China and the other from Europe, are pointing at a link between childhood trauma and Alzheimer disease. The first | Continue reading


@padiracinnovation.org | 2 years ago

Photobiomodulation: A proof of concept study in Parkinson disease

Parkinson's disease is a progressive neurodegenerative disease with no cure and few treatment options. Photobiomodulation has been used | Continue reading


@padiracinnovation.org | 2 years ago

Smoking may influence the risk of developing neurological diseases

In a new publication Gadd et al. apply blood-derived epigenetic signatures of lifestyle traits to matched blood and brain samples, uncovering | Continue reading


@padiracinnovation.org | 2 years ago

Precision Medicine and Alzheimer’s Disease: Successful Proof-of-Concept Trial

Alzheimer’s disease has become the third leading cause of death. Studies have provided candidate mechanisms for the neurodegeneration associated | Continue reading


@padiracinnovation.org | 2 years ago

Study of changes during aging in mice shows increased oxidative stress

The progression of aging-related traits varies considerably among individuals, influenced by their environment, lifestyle and genetics. The notion of | Continue reading


@padiracinnovation.org | 2 years ago

Better drainage of brain debris improves Alzheimer's disease therapies

In most of the organs of our body, the lymphatic system is responsible for conducting lymph between different parts of the body. The lymphatic system | Continue reading


@padiracinnovation.org | 3 years ago

Everything points to mTOR dysfunction in ALS

Here we review recent publications about ALS and try to connect the dots between autophagy, insulin resistance, C9orf72, FUS, proteopathies, | Continue reading


@padiracinnovation.org | 3 years ago

An ALS therapy poses a moral dilemma to Biogen

It was found in 2009 that toxicity of SOD1 is secondary to a gain of toxic function rather than a loss of enzymatic function of the SOD1 enzyme, thus | Continue reading


@padiracinnovation.org | 3 years ago

Donanemab, the first drug to succeed in an Early Alzheimer's Phase II trial

It has been clear for a while that anti-amyloid antibodies can sweep plaque from the brain, but until now the question of whether this slows | Continue reading


@padiracinnovation.org | 3 years ago

Kaempferol alleviates mitochondrial damage in a mice model of Parkinson

Parkinson's disease is a common neurodegenerative disease. Although the exact etiology and natural course of this disease have yet to be fully | Continue reading


@padiracinnovation.org | 3 years ago

Alteration in sarcoplasmic reticulum activity underlies muscle wasting in asthma

Links between severe forms of asthma and some ALS forms. I | Continue reading


@padiracinnovation.org | 3 years ago

Administration of mitochondria reverses chemotherapy-induced cognitive deficits

Nearly 3 out of 4 cancer patients undergoing chemotherapy suffer from loss of memory, attention or concentration. This range of cognitive | Continue reading


@padiracinnovation.org | 3 years ago

Development of an α-synuclein knockdown peptide in Parkinson’s disease models

Parkinson’s disease (Parkinson’s disease) is a major neurodegenerative disorder. It currently lacks a clinically relevant treatment that can | Continue reading


@padiracinnovation.org | 3 years ago

Development of an α-synuclein knockdown peptide in Parkinson’s disease models

Parkinson’s disease (Parkinson’s disease) is a major neurodegenerative disorder. It currently lacks a clinically relevant treatment that can | Continue reading


@padiracinnovation.org | 3 years ago

Improved mitochondria and ER stability improves SOD1 and TDP-43 ALS

Continue reading


@padiracinnovation.org | 3 years ago

Development of an α-synuclein knockdown peptide for Parkinson’s disease

Continue reading


@padiracinnovation.org | 3 years ago

Nucleolar stress precedes proteopathy in SLA

Continue reading


@padiracinnovation.org | 3 years ago

Chronic Intermittent Hypothermia Is Therapeutic in a Mouse Model of ALS

Continue reading


@padiracinnovation.org | 3 years ago

Evidence that brain iron in normal range is associated with Alzheimer's disease

Continue reading


@padiracinnovation.org | 3 years ago

Anomalous brain energy in old age by wavelet analysis of during a Stroop task

Continue reading


@padiracinnovation.org | 3 years ago

ALS, Hypermetabolism and Diet

Continue reading


@padiracinnovation.org | 3 years ago

Masitinib has achieved its main objective in a trial on Alzheimer’s disease

Continue reading


@padiracinnovation.org | 3 years ago

Transcription factor network analysis offers hope for CNS axon regeneration

Continue reading


@padiracinnovation.org | 3 years ago

Faze Medicines secures funding to study molecular condensates in ALS

Continue reading


@padiracinnovation.org | 3 years ago

AMX0035, Some Differing Opinions

Continue reading


@padiracinnovation.org | 3 years ago

Do not curse the darkness of the spinal cord, light TDP-43

Continue reading


@padiracinnovation.org | 3 years ago

A new neutrophil subset promotes CNS neuron survival and axon regeneration

Continue reading


@padiracinnovation.org | 3 years ago

Dihydrotestosterone in Amyotrophic lateral sclerosis, the missing link?

Continue reading


@padiracinnovation.org | 3 years ago

Monoclonal full-length antibody against TDP-43

Continue reading


@padiracinnovation.org | 3 years ago

A hypothesis linking diet and Alzheimer's disease

Continue reading


@padiracinnovation.org | 3 years ago

Parkinson's disease is not one but two diseases

Continue reading


@padiracinnovation.org | 3 years ago

Can molecular scientists fix neurodegenerative diseases?

Continue reading


@padiracinnovation.org | 3 years ago

Fasciculations in Amyotrophic Lateral Sclerosis

Continue reading


@padiracinnovation.org | 3 years ago